AbbVie | Despesas De Vendas E Administração



Selling And Administration Expenses Alterar Data
AbbVie USD 3.29B 562M 2025-03
Abbott USD 3.05B 144M 2025-03
ALKERMES USD 171.7M 24.71M 2025-03
Amgen USD 1.69B 191M 2025-03
AstraZeneca USD 3.59B 1.96B 2025-03
Biogen USD 572.5M 104.8M 2025-03
BioMarin Pharmaceutical USD 206.12M 50.65M 2025-03
Bristol-Myers Squibb USD 1.58B 521M 2025-03
Eisai JPY 106.51B 1.99B 2025-03
Eli Lilly USD 2.36B 62.3M 2025-03
Gilead Sciences USD 1.26B 603M 2025-03
GlaxoSmithKline GBP 2.06B 603M 2025-03
J&J USD 5.11B 1.34B 2025-03
Medtronic USD 2.7B 17M 2025-04
Merck USD 2.53B 319M 2025-03
Neurocrine Biosciences USD 287.8M 53.5M 2024-12
Novartis USD 3.5B 368M 2024-12
Pacira USD 86.78M 7.16M 2025-03
Perrigo USD 281.2M 46.4M 2025-03
Pfizer USD 3.01B 1.27B 2025-03
Regeneron Pharmaceuticals USD 633M 159.2M 2025-03
Roche Holding CHF 3.61B 381M 2024-12
Sanofi EUR 2.22B 980M 2025-03
UCB EUR 533M 434M 2024-06
Ultragenyx Pharmaceutical USD 87.8M 5.3M 2025-03
United Therapeutics USD 170.1M 7.6M 2025-03
Vertex Pharmaceuticals USD 377.6M 5.8M 2024-12
Zoetis USD 563M 62M 2025-03



AbbVie Despesas De Vendas E Administração - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.